天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

Welcome to chemicalbook!
+1 (818) 612-2111
Inquriy
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >API>Antibiotics>Eravacycline
Eravacycline
  • Eravacycline
  • Eravacycline
  • Eravacycline

Eravacycline NEW

Price Get Latest Price
Package 10mg 30mg 100mg
Min. Order: 10mg
Supply Ability: 1000000
Update Time: 2024-12-26
Related documents: MSDS NMR COA IR

Product Details

Product Name: Eravacycline CAS No.: 1207283-85-9
Min. Order: 10mg Purity: 95%+
Supply Ability: 1000000 Release date: 2024/12/26
Eravacycline
Article illustration



We have a complete set of impurities, all available in stock. Please contact us if you have any needs.



Article illustrationArticle illustrationArticle illustration


Eravacycline Impurity Reference Standards

Product Details:

Eravacycline impurity reference standards are crucial tools for detecting and verifying the purity and quality of eravacycline. These reference standards are produced according to strict standards and quality control procedures to ensure their accuracy and reliability.

Product Features:

  1. High Purity: The purity of the impurity reference standards is above 95%, ensuring the accuracy of test results.

  2. Multiple Specifications: Various specifications and packaging options are available to meet the needs of different customers.

  3. Comprehensive Testing: Equipped with basic detection methods such as COA (Certificate of Analysis), HPLC (High-Performance Liquid Chromatography), H-NMR (Proton Nuclear Magnetic Resonance), and MS (Mass Spectrometry). Additional testing can be conducted based on customer requirements.

  4. Excellent Service: Custom synthesis services are provided to meet the specific needs of customers.

Applications:

Eravacycline impurity reference standards are widely used in new drug research, drug registration, consistency evaluation, and drug quality control. They play a vital role in the new drug application and drug registration processes, helping to improve the purity and quality of drugs, thereby enhancing their efficacy and safety.

Article illustration


Company Profile Introduction

1. Drug standards and drug impurity reference substances: provide more than 20,000 kinds of spot impurity reference substances, with sufficient supply and same-day delivery. We have a professional R&D team and comprehensive quality control testing to ensure product quality and reliability. 2. Customized synthesis of impurities and new molecules: Quickly respond to the customized needs of CDE impurities, stably supply impurities that have established quality standards, and provide customized synthesis services for new compounds in the research and development of innovative drugs. 3. Preparation and separation of unknown impurities: With a professional impurity preparation and separation technical team and SFC preparation and separation instruments, we can solve the problems of impurity preparation in complex projects. 4. Process development of new drug intermediates: provide the supply of new drugs and new molecular impurities, process optimization services, as well as the screening and impurity analysis of commercialization routes. 5. Peptide synthesis: Provide customized peptide synthesis services, and cover all kinds of degradation impurities and process impurities generated in the research and development of peptide drugs. At the same time, it provides comprehensive structural confirmation data and customized testing services.

You may like

Recommended supplier

Product name Price   Suppliers Update time
$6700.00/100mg
VIP3Y
TargetMol Chemicals Inc.
2024-11-19
$0.10/1KG
VIP6Y
Shaanxi Dideu Medichem Co. Ltd
2024-08-04
$0.00/1kg
VIP5Y
Hebei Yanxi Chemical Co., Ltd.
2023-08-16
$1.00/1KG
VIP6Y
Career Henan Chemical Co
2020-01-01
  • Since: 2022-11-29
  • Address: Room 005-01, 15th Floor, Building D2, Phase III, Software New Town, No. 8 Huacheng Avenue, East Lake
INQUIRY